Toggle navigation
Home
Online Content
Archive up until volume 100, 2020
Volume 101, 2021 and onwards
Submit a new manuscript
Resubmit a manuscript in the old system
Title
Author
Abstract
DOI
Keyword
Content
»
Vol 93, Issue 2
Letter to the Editor
Tweet
Abstract
PDF
Long-term Treatment of Severe Recalcitrant Atopic Dermatitis with Omalizumab, an Anti-immuno-globulin E
Supplementary content
Table SI
Licenses
This work is licensed under a
Creative Commons Attribution-NonCommercial 4.0 International License
.
